A 32-year-old woman presents with a 5-day history of productive cough, fever (38.5°C), and dyspnea. Chest X-ray shows bilateral interstitial infiltrates. Sputum Gram stain reveals gram-negative coccobacilli. She reports a recent trip to a poultry farm. Blood cultures remain negative after 48 hours. She is started on azithromycin 500 mg daily. On day 3 of therapy, she develops severe nausea, abdominal cramping, and watery diarrhea. Stool culture is negative for common pathogens. What is the most likely explanation for her gastrointestinal symptoms?

Explanation

## Analysis of Gastrointestinal Adverse Effect of Azithromycin **Key Point:** The most common and well-established cause of gastrointestinal side effects with azithromycin (nausea, abdominal cramping, diarrhea) is its **motilin receptor agonist activity**, which directly stimulates gut motility and can irritate the intestinal mucosa — not *C. difficile* infection. ### Mechanism of Azithromycin-Induced GI Symptoms 1. **Motilin receptor agonism**: Azithromycin (and macrolides in general) structurally resemble motilin and bind to motilin receptors in the gut wall, causing premature and exaggerated peristaltic contractions 2. **Direct mucosal irritation**: High luminal concentrations of azithromycin can irritate the gastrointestinal mucosa, contributing to nausea and cramping 3. **Rapid onset**: These effects typically appear within the first few days of therapy — consistent with day 3 onset in this patient 4. **Incidence**: GI adverse effects occur in up to 35% of patients on azithromycin, making it the most common adverse effect class (KD Tripathi, 8th ed., Ch. 45) ### Why C. difficile Infection (Option D) Is Incorrect Here | Feature | CDI | This Case | |---------|-----|-----------| | Typical onset | Usually ≥5–10 days after antibiotics (can be up to 8 weeks) | Day 3 — too early for CDI | | Stool findings | Toxin-positive; may show pseudomembranes | Stool culture negative (but CDI requires toxin assay, not culture) | | Risk with azithromycin | Low-to-moderate (lower than clindamycin/fluoroquinolones) | CDI is not the primary concern at day 3 | | Mechanism | Dysbiosis → *C. difficile* overgrowth | Not consistent with 3-day timeline | **High-Yield:** Macrolides are among the most common causes of antibiotic-associated GI side effects due to their **prokinetic (motilin agonist) mechanism**. This is a direct pharmacological effect, not an immune-mediated or dysbiosis-driven process. Erythromycin is actually used therapeutically as a prokinetic agent for gastroparesis at sub-antimicrobial doses — illustrating this same mechanism. **Clinical Pearl:** When a patient develops nausea, abdominal cramping, and diarrhea within the first 3 days of azithromycin therapy, the most likely explanation is **direct GI toxicity via motilin receptor stimulation**, not *C. difficile* colitis (which requires a longer latency period and would be diagnosed by toxin assay, not routine stool culture). The negative stool culture for common pathogens further supports a drug-induced rather than infectious etiology. ### Why Other Options Are Incorrect - **Option A (Allergic reaction):** True IgE-mediated allergic reactions to macrolides are rare and typically manifest as urticaria, angioedema, or anaphylaxis — not isolated enteritis - **Option B (Worsening respiratory infection with GI involvement):** The organism (*Chlamydophila psittaci* from poultry exposure) can rarely cause GI symptoms, but the temporal association with azithromycin initiation makes drug-induced GI toxicity far more likely - **Option D (C. difficile):** Requires longer antibiotic exposure (typically >5–10 days) and is diagnosed by toxin detection, not routine culture; day 3 onset is too early [cite: KD Tripathi Essentials of Medical Pharmacology, 8th ed., Ch. 45 — Macrolide Antibiotics; Harrison's Principles of Internal Medicine, 21st ed.]